These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 36365230)
1. Fused Deposition Modeling (FDM) 3D Printing of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate. Hoffmann L; Breitkreutz J; Quodbach J Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365230 [TBL] [Abstract][Full Text] [Related]
2. Hot-Melt Extrusion of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate. Hoffmann L; Breitkreutz J; Quodbach J Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297525 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing. Hoffmann L; Breitkreutz J; Quodbach J Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059 [TBL] [Abstract][Full Text] [Related]
4. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
5. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Alhijjaj M; Belton P; Qi S Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210 [TBL] [Abstract][Full Text] [Related]
6. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing. Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075 [TBL] [Abstract][Full Text] [Related]
7. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing. Zhang P; Xu P; Chung S; Bandari S; Repka MA Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460 [TBL] [Abstract][Full Text] [Related]
9. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary. Serajuddin ATM ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904 [TBL] [Abstract][Full Text] [Related]
10. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing. Chung S; Zhang P; Repka MA Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727 [TBL] [Abstract][Full Text] [Related]
11. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance. Bandari S; Nyavanandi D; Dumpa N; Repka MA Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550 [TBL] [Abstract][Full Text] [Related]
12. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
13. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
14. [Preparation and Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356 [TBL] [Abstract][Full Text] [Related]
15. Paliperidone palmitate as model of heat-sensitive drug for long-acting 3D printing application. Manini G; Benali S; Mathew A; Napolitano S; Raquez JM; Goole J Int J Pharm; 2022 Apr; 618():121662. PubMed ID: 35292399 [TBL] [Abstract][Full Text] [Related]
16. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment. Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925 [TBL] [Abstract][Full Text] [Related]
17. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
18. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution. Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418 [TBL] [Abstract][Full Text] [Related]
19. Effect of pH, Ionic Strength and Agitation Rate on Dissolution Behaviour of 3D-Printed Tablets, Tablets Prepared from Ground Hot-Melt Extruded Filaments and Physical Mixtures. Nashed N; Chan S; Lam M; Ghafourian T; Nokhodchi A Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830914 [TBL] [Abstract][Full Text] [Related]
20. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing. Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]